The 2024 Headache editorial board Conflict of Interest Declarations.

IF 5.4 2区医学 Q1 CLINICAL NEUROLOGY Headache Pub Date : 2024-09-01 Epub Date: 2024-07-16 DOI:10.1111/head.14793

Jenn Vallimont

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2024 Headache》编辑部利益冲突声明。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Headache 医学-临床神经学

CiteScore

9.40

自引率

10.00%

发文量

172

审稿时长

3-8 weeks

期刊介绍： Headache publishes original articles on all aspects of head and face pain including communications on clinical and basic research, diagnosis and management, epidemiology, genetics, and pathophysiology of primary and secondary headaches, cranial neuralgias, and pains referred to the head and face. Monthly issues feature case reports, short communications, review articles, letters to the editor, and news items regarding AHS plus medicolegal and socioeconomic aspects of head pain. This is the official journal of the American Headache Society.

期刊最新文献

Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study. Anxiety, depression, and headache-related disability in a large pediatric clinic-based sample. Associations of comorbid headache disorders and depression with leisure-time physical activity among 14,088 adults in The Brazilian Longitudinal Study of Adult Health. Magnetoencephalography studies in migraine and headache disorders: A systematic review. Comparative bioavailability of single-dose zavegepant during and between migraine attacks: A phase 1, randomized, open-label, fixed-sequence, two-period study.